FLUPHENAZINE OMEGA DIN 02242570
Health Canada record
| Active ingredient(s) | FLUPHENAZINE DECANOATE 100 MG |
|---|---|
| Dosage form | Liquid |
| Route | Intramuscular; Subcutaneous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N05AB02 FLUPHENAZINE |
| Original market date | 20-Nov-2000 |
| Current status date | 29-Jul-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Omega Laboratories Ltd. (now Juno Pharma Canada Inc.) — licence 100277, not currently licensed, last inspection rating C (2025-05-20).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FLUPHENAZINE DECANOATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02244166 | APO-FLUPHENAZINE INJECTABLE | APOTEX INC | Liquid | FLUPHENAZINE DECANOATE 25 MG | Cancelled Post Market |
| 02189089 | FLUPHENAZINE DECANOATE INJECTION B.P. | HOSPIRA HEALTHCARE ULC | Liquid | FLUPHENAZINE DECANOATE 25 MG | Cancelled Pre Market |
| 02189097 | FLUPHENAZINE DECANOATE INJECTION B.P. | HOSPIRA HEALTHCARE ULC | Liquid | FLUPHENAZINE DECANOATE 100 MG | Cancelled Pre Market |
| 02383225 | FLUPHENAZINE DECANOATE INJECTION, USP | MYLAN PHARMACEUTICALS ULC | Solution | FLUPHENAZINE DECANOATE 25 MG | Cancelled Pre Market |
| 02239636 | FLUPHENAZINE OMEGA | OMEGA LABORATORIES LIMITED | Liquid | FLUPHENAZINE DECANOATE 25 MG | Cancelled Post Market |
| 00755575 | MODECATE CONCENTRATE | BRISTOL-MYERS SQUIBB CANADA | Liquid | FLUPHENAZINE DECANOATE 100 MG | Cancelled Post Market |
| 00349917 | MODECATE INJ 25MG/ML | SQUIBB CANADA INC., DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | Liquid | FLUPHENAZINE DECANOATE 25 MG | Cancelled Post Market |
| 02241928 | PMS-FLUPHENAZINE DECANOATE | PHARMASCIENCE INC | Liquid | FLUPHENAZINE DECANOATE 100 MG | Cancelled Post Market |
| 02091275 | PMS-FLUPHENAZINE DECANOATE INJ (BP) 25MG/ML | PHARMASCIENCE INC | Solution | FLUPHENAZINE DECANOATE 25 MG | Cancelled Post Market |
| 02211157 | RHO-FLUPHENAZINE DECANOATE INJ-25MG/ML IM SC | RHODIAPHARM INC | Solution | FLUPHENAZINE DECANOATE 25 MG | Cancelled Post Market |
| 02211165 | RHO-FLUPHENAZINE DECANOATE INJ.CONC-100MG/ML | RHODIAPHARM INC | Solution | FLUPHENAZINE DECANOATE 100 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 1162 | 2000-07-27 | Abbreviated New Drug Submission (ANDS) |
International API supply for FLUPHENAZINE DECANOATE
2 valid EDQM Certificates of Suitability from 2 holders. 5 active FDA Drug Master Files.
Request a quote for FLUPHENAZINE OMEGA